Angel Yeast Cup Finals and Industry Development Conference Concludes
Engaging the World Through Fermented Flour-Based Foods SHANGHAI, Aug. 22, 2025 /PRNewswire/ -- The Finals of the 8th Angel Yeast Cup Chinese Fermented Dim Sum Contest and the 12th Fermented Flour-Based Food Industry Development Conference wrapped up in Ningxiang, Hunan province, a region widely recognized as the birthplace of Chinese staple foods. Sponsored...
Heartbeats Launches Digital Wellness Platform Led by World-Renowned Heart Specialist Dr. Hosen Kiat
SYDNEY, Aug. 22, 2025 /PRNewswire/ -- In an online world awash with wellness fads and misinformation, one of the world's most cited cardiologists has decided to step in. Dr Hosen Kiat, ranked among the top 1% of clinical researchers worldwide, has launched a YouTube channel dedicated to evidence-based advice on aging well — proving that age is no barrier to...
MALAYSIA SHOWCASES HEALTHCARE EXCELLENCE IN CAMBODIA, DRIVING MOMENTUM TOWARDS MYMT 2026
KUALA LUMPUR, Malaysia, Aug. 22, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) proudly presents Malaysia Healthcare Week 2025 in Phnom Penh, Cambodia, an initiative designed to strengthening healthcare ties between the two nations and position Malaysia as the medical tourism destination in the world. Taking place from 19 to 22...
Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore
SINGAPORE, Aug. 22, 2025 /PRNewswire/ -- Asia Bio Innovation Summit 2025 is one of the premier industry-focused events in Asia and focus on the hottest topics of ADC and CGT. Asia Bio Innovation summit 2025 Singapore brought together 30+ world-class Speakers, 10+ Exhibitors and 200+ Attendees from regulatory authority, big pharma, biotech, academia, CXO and etc, to harness the full...
Orange Biomed Lands on Fortune Korea’s Top 40 with Portable Diabetes Test
SEATTLE, Aug. 22, 2025 /PRNewswire/ -- Orange Biomed, developer of the world's first pocket-sized A1C testing device, is receiving international recognition for its breakthrough microfluidic technology designed to enhance accessibility and accuracy in chronic disease management. The company has been selected for inclusion in Fortune Korea's "Top 40 Emerging South Korean Healthcare Innovations", highlighting its growing momentum in the U.S....
Doceree launches Premium Programmatic adding more context, more reach, and more formats to traditional HCP programmatic
With Premium Programmatic, pharma marketers can now engage physicians across 2,000+ integrated specialist medical platforms delivering clinically aligned content at scale with unmatched precision and exclusive formats. SHORT HILLS, N.J., Aug. 21, 2025 /PRNewswire/ -- Doceree, the only AI-powered operating system for healthcare marketing, today announced the launch of Premium...
BioDlink’s Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization
Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Control (BPOM), following Nigeria, Pakistan, and Colombia – accelerating global commercialization Approval in ASEAN's largest pharma market strengthens BioDlink's position as a global supplier of antibody/XDC therapies via international GMP standards and commercial capabilities SUZHOU, China, Aug....
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health
Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to Korea. Both reviews expanded cooperation, including next-generation preventive medicines. SEONGNAM, South Korea, Aug. 21, 2025 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today...
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. JENA, Germany, Aug. 21, 2025 /PRNewswire/ -- ZEISS Medical Technology today announced CE mark approval for CIRRUS® PathFinder™, an innovative clinical support tool with artificial intelligence (AI) fully...
FDA clearance of Salix® Coronary Plaque module
Significantly expands U.S. commercial opportunity with ability to charge fees per scan assessed Investor Webinar - 11.30am AEST (9.30am AWST) on 22 August 2025 PERTH, Australia, Aug. 21, 2025 /PRNewswire/ -- Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology company commercialising its Salix® AI-powered cloud platform, for the near real time, point of care assessment and management...














